Literature DB >> 218670

Mecillinam in enteric fever.

B K Mandal, A G Ironside, J Brennand.   

Abstract

Twelve consecutive patients with enteric fever entered a trial of 14 days' treatment with mecillinam. Only three patients became afebrile within three days; four continued unimproved with fever and toxaemia for seven to nine days, when treatment was changed to chloramphenicol with good results. In one case the fever did not settle until the 13th day, and five days later the patient had a clinical relapse. Although all organisms recovered were fully sensitive to mecillinam, this drug is not an effective or consistent treatment for enteric fever.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 218670      PMCID: PMC1598378          DOI: 10.1136/bmj.1.6163.586

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  1 in total

Review 1.  Chemotherapy of typhoid fever: a review of literature.

Authors:  C Herzog
Journal:  Infection       Date:  1976       Impact factor: 3.553

  1 in total
  4 in total

Review 1.  Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections.

Authors:  John A Crump; Maria Sjölund-Karlsson; Melita A Gordon; Christopher M Parry
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

2.  Treatment of experimental Salmonella typhimurium infection with mecillinam and ampicillin.

Authors:  T Butler; C W Shuster; P Dixon
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

3.  The combination of pivmecillinam and pivampicillin compared to co-trimoxazole in the treatment of enteric fever.

Authors:  D Tanphaichitra; A Bussayanond; O Christensen
Journal:  Infection       Date:  1982       Impact factor: 3.553

4.  Ceftriaxone-resistant Salmonella enterica serotype Typhi in a pregnant traveller returning from Karachi, Pakistan to Denmark, 2019.

Authors:  Anne Line Engsbro; Hans Søe Riis Jespersen; Maria Ingeborg Goldschmidt; Sarah Mollerup; Peder Worning; Martin Schou Pedersen; Henrik Westh; Uffe Vest Schneider
Journal:  Euro Surveill       Date:  2019-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.